Paraneoplastic limbic encephalitis following treatment with single-agent pembrolizumab for advanced gastroesophageal adenocarcinoma
10.1136/bcr-2021-247676
May 24, 2022
Immunological products and vaccines
Acute interstitial nephritis after COVID-19 vaccination
10.1136/bcr-2021-246841
May 19, 2022
Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination
10.1136/bcr-2021-247346
May 19, 2022
Non-arteritic anterior ischaemic optic neuropathy (NA-AION) and COVID-19 vaccination
10.1136/bcr-2021-248415
May 13, 2022
Management of a severe bilateral pulmonary embolism as a complication of VITT following vaccination with AstraZeneca COVID-19 vaccine
10.1136/bcr-2021-246770
May 11, 2022
Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis
10.1136/bcr-2021-245749
April 29, 2022
Vaccine-induced thrombosis and thrombocytopaenia with widespread abdominal venous thrombosis, venous ischaemia and bowel oedema
10.1136/bcr-2021-247996
April 6, 2022
Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine
10.1136/bcr-2022-249237
March 30, 2022
T-cell prolymphocytic leukaemia associated with immune checkpoint inhibitor (pembrolizumab)
10.1136/bcr-2021-245603
March 29, 2022
Thrombotic thrombocytopenic purpura following administration of the Moderna booster vaccine
10.1136/bcr-2021-247576
March 24, 2022